AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 288: H2484-H2490, 2005. First published January 6, 2005; doi:10.1152/ajpheart.00848.2004
0363-6135/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/5/H2484    most recent
00848.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Portman, M. A.
Right arrow Articles by Ning, X.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Portman, M. A.
Right arrow Articles by Ning, X.-H.

Direct action of T3 on phosphorylation potential in the sheep heart in vivo

Michael A. Portman,1,2 Kun Qian,1 Julia Krueger,1 and Xue-Han Ning1,2

1Division of Cardiology, Department of Pediatrics, University of Washington School of Medicine, and 2Children's Hospital and Regional Medical Center, Seattle, Washington

Submitted 19 August 2004 ; accepted in final form 20 December 2004

Thyroid acting through ligand binding to nuclear receptors modifies myocardial respiratory kinetics and oxidative phosphorylation in the heart. Direct nongenomic action of thyroid hormone on high-energy phosphate concentrations and respiratory kinetics has never been proven in vivo but might be responsible for observed changes in oxygen utilization efficiency immediately after triiodothyronine (T3) administration. We tested the hypothesis that T3 directly and rapidly modifies myocardial high-energy phosphate concentrations and phosphorylation potential in vivo. Anesthetized sheep (age 28–40 days) thyroidectomized shortly after birth (Thy) and euthyroid age-matched controls (Con) underwent median sternotomy and received T3 infusion (0.8 µg/kg), followed by epinephrine infusion to increase myocardial oxygen consumption (MO2). 31P magnetic resonance spectra were monitored via a surface coil over the left ventricle. T3 increased phosphocreatine (PCr)/ATP and decreased ADP in Thy animals without causing a change in MO2. T3 produced no changes in high-energy phosphates in Con animals. T3 did not modify the PCr/ATP or ADP response to epinephrine and elevation in MO2 in either group. Cardiac mitochondria isolated from Thy and Con animals showed no change in respiratory rate or ADP/ATP exchange efficiency after T3 incubation. T3 infusion in a hypothyroid state decreases ADP concentration, thereby altering the equilibrium between phosphorylation potential and myocardial respiratory rate. These T3-induced effects are not due to changes in ADP/ATP exchange efficiency through action at the adenine nucleotide translocator but may be due to T3 mediation of substrate utilization, confirmed in other models.

adenine nucleotide translocator; myocardial energy metabolism; substrate oxidation



Address for reprint requests and other correspondence: M. A. Portman, Children's Hospital and Regional Medical Center, 4G-01, Seattle, WA 98105 (E-mail: michael.portman{at}seattlechildrens.org)




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
O. M. Hyyti, A. K. Olson, M. Ge, X.-H. Ning, N. E. Buroker, Y. Chung, T. Jue, and M. A. Portman
Cardioselective dominant-negative thyroid hormone receptor ({Delta}337T) modulates myocardial metabolism and contractile efficiency
Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E420 - E427.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. E. Buroker, M. E. Young, C. Wei, K. Serikawa, M. Ge, X.-H. Ning, and M. A. Portman
The dominant negative thyroid hormone receptor beta-mutant {Delta}337T alters PPAR{alpha} signaling in heart
Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E453 - E460.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
O. M. Hyyti, X.-H. Ning, N. E. Buroker, M. Ge, and M. A. Portman
Thyroid hormone controls myocardial substrate metabolism through nuclear receptor-mediated and rapid posttranscriptional mechanisms
Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E372 - E379.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. D. McClure, M. E. Young, H. Taegtmeyer, X.-H. Ning, N. E. Buroker, J. Lopez-Guisa, and M. A. Portman
Thyroid hormone interacts with PPAR{alpha} and PGC-1 during mitochondrial maturation in sheep heart
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2258 - H2264.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.